|
The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) Clinical research trials and The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF). The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) clinical trial. Participants typically obtain the most effective healthcare available for their The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)  The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)
The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)
For Condition: Idiopathic Pulmonary Fibrosis,Lung Disease,Pulmonary Fibrosis
Status: Recruiting
Sponsor(s): InterMune ,
Synopsis: - Purpose: A phase 3, randomized, double-blind, placebo-controlled trial to determine the efficacy and safety of 200 µg of recombinant Interferon gamma-1b administered by subcutaneous (SC) injection, compared with placebo, in patients with IPF - Enrollment: 600 patients will be enrolled from approximately 70 centers in North America and Europe - Randomization: 2:1 active-to-placebo ratio - Duration: 2 years active drug or placebo (rescue therapy will be permitted for patients who meet predefined criteria)
Details: INSPIRE, the largest and most comprehensive clinical trial ever conducted in IPF, is now enrolling patients with mild to moderate IPF. Eligible patients will receive either Interferon gamma-1b or placebo for a minimum of 2 years.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 40 Years/79 Years
Genders: Both
Protocol Entry Criteria: - Ages 40-79 - Diagnosis of IPF based on ATS/ERS criteria within past 36 months - Definite or probable IPF on high-resolution computed tomography (HRCT) - Surgical lung biopsy or nondiagnostic bronchoscopy - Evidence of disease progression within past year - FVC within 55-90% of predicted value - DLCO within 35-90% of predicted value
Total Enrollment: 600
Location and Contact Information:
InterMune, Inc. *Recruiting*
Brisbane, California, 94005
United States
Recruiting INSPIRE Trial
Additional Information:
Study ID Numbers: GIPF-007;
Study Start Date: December 2003
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00075998
Other Idiopathic Pulmonary Fibrosis Studies:
1. An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF
2. Evaluation and Treatment of Patients with Lung Disease not Participating in Research
3. Biomarkers of Benzene Exposure in Inner City Residents
4. Natrecor in Pulmonary Hypertension
5. Effects of Endotoxin in Normal Human Volunteers
Related Studies:
Other Idiopathic Pulmonary Fibrosis Clinical Trials
Other California Clinical Trials
Other Brisbane Clinical Trials
The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)
|
|
|
|
|
|
|
|
